Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation

Transplant Proc. 1998 Aug;30(5):1671-2. doi: 10.1016/s0041-1345(98)00386-8.

Authors

M A Gómez-Sánchez¹, J F Delgado, P Escribano, M Santos, T Sotelo, R Gil, J Hernández-Afonso, B Ortuño, F Romero, C Sáenz de la Calzada, J E Rodriguez, J J Rufilanchas

Affiliation

¹ Heart Failure and Transplantation Program, Hospital 12 de Octubre, Madrid, Spain.

PMID: 9723237
DOI: 10.1016/s0041-1345(98)00386-8

No abstract available

MeSH terms

Cyclosporine / blood*
Cyclosporine / therapeutic use
Drug Monitoring
Drug Therapy, Combination
Female
Graft Rejection / epidemiology*
Graft Rejection / prevention & control
Heart Transplantation / immunology*
Heart Transplantation / mortality
Heart Transplantation / physiology
Hemodynamics
Humans
Immunosuppressive Agents / blood*
Immunosuppressive Agents / therapeutic use
Incidence
Male
Methylprednisolone / therapeutic use
Middle Aged
Muromonab-CD3 / therapeutic use
Postoperative Period
Retrospective Studies
Survival Rate
Time Factors

Substances

Immunosuppressive Agents
Muromonab-CD3
Cyclosporine
Methylprednisolone